- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02355392
Prevalence of Hypertension Using Telemedical Home Blood Pressure Measurements
January 30, 2015 updated by: Erling Bjerregaard Pedersen
The purpose of this study is to determine the prevalence of hypertension among citizens of Holstebro, Denmark aged 55-64 years, including both the well treated, the untreated and the insufficiently treated, and to estimate the prevalence of white coat and masked hypertension using home blood pressure measurements with telemedical data transmission.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
3159
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
55 years to 64 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
A population study in the municipality of Holstebro, which has 57.000 inhabitants.
Using the Civil Registration System, we invite all citizens aged 55-64 years.
Description
Inclusion Criteria:
- Age 55 to 64 years
- Registered address in the municipality of Holstebro
- Enrolment at a practice of one of the GPs who had agreed to participate in the study.
Exclusion Criteria:
- Unwillingness to participate
- Incapability to do home blood pressure measurements
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Office blood pressure
Time Frame: 10 minuttes
|
10 minuttes
|
Telemedical home blood pressure
Time Frame: 3 days
|
3 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Nikolai Hoffmann-Petersen, MD, Department of Medical Research and Medicine, Holstebro Regional Hospital, Holstebro, Denmark
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2011
Primary Completion (Actual)
October 1, 2014
Study Completion (Actual)
October 1, 2014
Study Registration Dates
First Submitted
January 30, 2015
First Submitted That Met QC Criteria
January 30, 2015
First Posted (Estimate)
February 4, 2015
Study Record Updates
Last Update Posted (Estimate)
February 4, 2015
Last Update Submitted That Met QC Criteria
January 30, 2015
Last Verified
January 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- M-20110011
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
BayerCompletedPrimary HypertensionChina
-
Addpharma Inc.Completed
-
Columbia UniversityAgency for Healthcare Research and Quality (AHRQ)Active, not recruitingWhite Coat Hypertension | Hypertension,EssentialUnited States
-
Universidade Federal de Santa MariaCompletedHealthy Volunteers | Hypertension, EssentialBrazil
-
Cytos Biotechnology AGCompletedMild Essential Hypertension | Moderate Essential HypertensionSwitzerland
-
Sulaiman AlRajhi CollegesUnknownHypertension, Essential | β-hydroxybutyrate
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of SheffieldCompletedIdiopathic Pulmonary Arterial Hypertension | Chronic Thromboembolic Pulmonary HypertensionUnited Kingdom
Clinical Trials on Telemedical home blood pressure measurements
-
Erling Bjerregaard PedersenCompleted
-
Regional Hospital HolstebroCompleted
-
North-West University, South AfricaUniversity of Zurich; University of Cape Town; Medical Research Council, South... and other collaboratorsRecruitingHypertension | Obesity, Childhood | Obesity, AdolescentSouth Africa, Switzerland
-
Boehringer IngelheimCompleted
-
Oslo University HospitalRecruitingCardiovascular Diseases | Hypertension | Kidney Transplant; ComplicationsNorway
-
Hasselt UniversityJessa HospitalCompleted
-
Boryung Pharmaceutical Co., LtdUnknownHypertensionKorea, Republic of
-
Meir Medical CenterNovartis PharmaceuticalsTerminatedBlood Pressure, HighIsrael
-
Muhimbili University of Health and Allied SciencesCompletedHIV Infections | Hypertension | Diabetes MellitusTanzania